Randomized Controlled Open-Label Parallel Group Multi-Center Prospective Phase 4 Study Comparing the Efficacy of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2 3 and 4 Pressure Injuries

Brief description of study

This research is studying a powder wound dressing called Altrazeal®, also called Transforming Powder Dressing (TPD). TPD will be used in this study to treat pressure injuries and will be compared to treatment of pressure injuries using the normal care, also called Standard of Care (SOC) used by your health care provider. When you have a pressure injury, or open wound caused by pressure, your doctor will treat it using some type of dressing. There are many types of dressing, including gauze, films, foams, and others. This research will specifically focus on the effect TPD has on the number of dressing changes, as compared to the currently used SOC treatment. All subjects in this study will receive study treatment either with TPD or with another type of commonly used dressing under current standard of care guidelines.

Clinical Study Identifier: s21-01696
ClinicalTrials.gov Identifier: NCT05496296
Principal Investigator: Scott A Gorenstein.
Other Investigator: Brian Gillette.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.